alpheon
biopartners gmbh - recombinant human interferon alfa-2a - epatite c, cronica - immunostimolanti, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.
morbilgamma
farma biagini spa - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
immunomorb
istituto sierovaccinogeno italiano i.s.i. s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
moruman berna
istituto sieroterapico e vaccinogeno svizzero berna - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
uman big
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
haimabig
hardis s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
hepuman b
crucell italy s.r.l. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
immunohbs
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
hepatect
biotest pharma gmbh - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b
venbig
kedrion s.p.a. - immunoglobulina anti-epatite b - immunoglobulina anti-epatite b